Q3 2025 · 13F-HR
AIGH Capital Management LLCholdings as filed
Filed 2025-10-31 · accession 0001214659-25-015641
$354.9M
Reported value
38
Positions
2025-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G7997R903 | — | SEAGATE TECHNOLOGY HLDNGS PL | $37.9M | 10.7% | 12,470,132 | CALL | SOLE |
| 80004C200 | SNDK | SANDISK CORP | $31.4M | 8.85% | 280,000 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $25.4M | 7.15% | 3,892,101 | Common | SOLE |
| 257554105 | DOMO | DOMO INC | $21.2M | 5.99% | 1,341,518 | Common | SOLE |
| 00770C101 | ARQ | ARQ INC | $18.5M | 5.20% | 2,579,486 | Common | SOLE |
| 57776J100 | MXL | MAXLINEAR INC | $17.8M | 5.02% | 1,107,504 | Common | SOLE |
| 65487K100 | LASR | NLIGHT INC | $17.8M | 5.01% | 600,103 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $16.1M | 4.54% | 707,287 | Common | SOLE |
| 550241103 | LUMN | LUMEN TECHNOLOGIES INC | $15.6M | 4.40% | 2,550,000 | Common | SOLE |
| 219350105 | GLW | CORNING INC | $12.3M | 3.48% | 3,829,453 | CALL | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $11.7M | 3.30% | 1,231,932 | Common | SOLE |
| 60741F104 | MBLY | MOBILEYE GLOBAL INC | $11.3M | 3.19% | 4,423,008 | CALL | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $10.7M | 3.02% | 1,520,492 | Common | SOLE |
| 25400W102 | APPS | DIGITAL TURBINE INC | $9.7M | 2.75% | 1,523,068 | Common | SOLE |
| 05587G203 | BKTI | BK TECHNOLOGIES CORPORATION | $8.4M | 2.36% | 99,009 | Common | SOLE |
| 92835K103 | VPG | VISHAY PRECISION GROUP INC | $8.0M | 2.26% | 250,000 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $8.0M | 2.24% | 3,000,000 | Common | SOLE |
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $7.7M | 2.16% | 3,221,110 | CALL | SOLE |
| 532257805 | LPTH | LIGHTPATH TECHNOLOGIES INC | $7.1M | 2.01% | 900,000 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $6.4M | 1.80% | 681,501 | Common | SOLE |
| 22407B108 | COYA | COYA THERAPEUTICS INC | $6.3M | 1.78% | 1,105,622 | Common | SOLE |
| 92259N302 | VELO | VELO3D INC | $5.3M | 1.49% | 1,719,874 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $5.0M | 1.42% | 429,000 | Common | SOLE |
| G037AX101 | AMBA | AMBARELLA INC | $4.1M | 1.16% | 50,000 | Common | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $4.0M | 1.12% | 4,454,545 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $3.6M | 1.00% | 1,065,128 | Common | SOLE |
| 75989R107 | RNXT | RENOVORX INC | $3.3M | 0.94% | 2,615,193 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $3.2M | 0.91% | 1,000,000 | Common | SOLE |
| 05479K106 | ELUT | ELUTIA INC | $2.8M | 0.79% | 3,165,128 | Common | SOLE |
| 92921W300 | VUZI | VUZIX CORP | $2.8M | 0.79% | 898,648 | Common | SOLE |
| 00439U104 | GRCE | GRACE THERAPEUTICS INC | $2.7M | 0.76% | 907,217 | Common | SOLE |
| 451622203 | IPWR | IDEAL PWR INC | $2.6M | 0.73% | 513,047 | Common | SOLE |
| 64134X201 | NRXS | NEURAXIS INC | $1.2M | 0.35% | 400,000 | Common | SOLE |
| 28617B606 | ELVA | ELECTROVAYA INC | $1.1M | 0.32% | 192,100 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $1.1M | 0.31% | 198,500 | Common | SOLE |
| 09077D209 | BFRI | BIOFRONTERA INC | $1.0M | 0.29% | 1,046,050 | Common | SOLE |
| 03836J201 | APRE | APREA THERAPEUTICS INC | $795,467 | 0.22% | 539,300 | Common | SOLE |
| 83193D203 | SMTK | SMARTKEM INC | $714,465 | 0.20% | 425,277 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.